Ultrasound Guided Modified Pectoral Plane Block Versus Erector Spinae Plane Block During GA in Gynecomastia Surgery

Ultrasound Guided Modified Pectoral Plane (PECS II )Block Versus Erector Spinae Plane (ESP) Block for Perioperative Analgesia of Surgical Treatment of Gynecomastia

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04221074

Enrollment

Registered

2020-01-09

Start date

2020-02-01

Completion date

2020-07-01

Last updated

2020-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecomastia, Adolescent

Brief summary

Pain of breast surgery is due to chest wall scar and arm in some cases like carcinoma or due to nerve injury.It is neuropathic or nociceptive pain.Its severity is depending on the extent of surgery and the radiotherapy if needed. Previous studies proved that local nerve block procedures improved the immediate postoperative pain and decreased the incidence of postoperative pain chronicity . Also effective control of pain suppresses the surgical stress response minimizes the anaesthestic needs intraoperatively and decreases the opioid needs postoperatively . Pectoralis nerve(pecs) II block and erector spinae plane (ESP) block are novel procedures that may provide good intraoperative and postoperative analgesia in patients undergoing surgical treatment of gynecomastia.

Interventions

PROCEDUREPECS II versus ESP

compare between :ultrasound guided Pectoralis nerve(pecs) II block or erector spinae plane (ESP) block in surgical treatment for gynecomastia patients under general anaesthesia.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

SINGLE (Caregiver)

Eligibility

Sex/Gender

MALE

Age

18 Years to 25 Years

Healthy volunteers

Yes

Inclusion criteria

* Male gender . * Age : 18 - 25 years old . * Physical status : ASA I - II . * Body mass index(BMI) :20-30 kg/m2 * Surgical treatment of Gynecomastia . * Duration of surgery : 60 -120 min

Exclusion criteria

* Patient refusal . * History of opioid abuse or chronic analgesic use . * Coagulopathy . * Allergy to study drugs . * Infection in the injection sites. * Uncooperative patients.

Design outcomes

Primary

Measure	Time frame	Description
intraoperative analgesia	60-120 minuets	measurement of intraoperative mean blood pressure (mmHg)

Secondary

Measure	Time frame	Description
postoperative analgesia	24 hours	evaluation of postoperative visual analogue scaleusing a ruler graded from 0 to 100 mm,where 0=no pain and 100=the worst imaginable pain measured in postanaesthesia care unit and every 6hours for 24 h postoperative.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026